Back |
home / stock / rgbp / rgbp message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: RGBP 27% v5M c.0019 H.0021 S.0016 seems to be strong f252,044,740 | znewcar1 | investorshangout | 04/11/2019 2:21:21 AM |
znewcar1: RGBP 43% v39M c.00230 f252,M H .0026 an hour into it then sideways | znewcar1 | investorshangout | 04/03/2019 9:47:15 PM |
znewcar1: RGBP 23% v11,M c.0016 f252M H.0018 daily vol is sporadic yet has news. Been bearish since | znewcar1 | investorshangout | 04/03/2019 1:59:21 AM |
jedijazz: $RGBP FDA Play as Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead | jedijazz | investorshangout | 03/27/2019 2:13:11 PM |
jedijazz: $RGBP Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agon | jedijazz | investorshangout | 03/26/2019 12:43:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments PR Newswire SAN DIEGO , Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has announced that after interviewing sev...
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of its DuraCAR CAR T-cell therapeutic ( http...
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program PR Newswire Autoimmunity to be Targeted SAN DIEGO , Oct. 25, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) ...